IRADIMED Past Earnings Performance

Past criteria checks 5/6

IRADIMED has been growing earnings at an average annual rate of 27.7%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 16.8% per year. IRADIMED's return on equity is 22.3%, and it has net margins of 26.1%.

Key information

27.7%

Earnings growth rate

25.5%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate16.8%
Return on equity22.3%
Net Margin26.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How IRADIMED makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:46K Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 247119313
30 Jun 246919303
31 Mar 246818283
31 Dec 236617273
30 Sep 236316263
30 Jun 236015253
31 Mar 235614253
31 Dec 225313232
30 Sep 225013232
30 Jun 224812222
31 Mar 224510212
31 Dec 21429202
30 Sep 21386172
30 Jun 21355172
31 Mar 21321192
31 Dec 20321202
30 Sep 20344232
30 Jun 20365232
31 Mar 203910201
31 Dec 193910201
30 Sep 19368181
30 Jun 19348171
31 Mar 19327161
31 Dec 18306162
30 Sep 18295151
30 Jun 18273152
31 Mar 18252152
31 Dec 17230152
30 Sep 17221142
30 Jun 17243132
31 Mar 17295142
31 Dec 16327141
30 Sep 16358151
30 Jun 16359142
31 Mar 16338132
31 Dec 15318122
30 Sep 15265112
30 Jun 15224101
31 Mar 1519391
31 Dec 1415281
30 Sep 1415271
30 Jun 1414261
31 Mar 1412251
31 Dec 1311251

Quality Earnings: 46K has high quality earnings.

Growing Profit Margin: 46K's current net profit margins (26.1%) are higher than last year (25.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 46K's earnings have grown significantly by 27.7% per year over the past 5 years.

Accelerating Growth: 46K's earnings growth over the past year (14.1%) is below its 5-year average (27.7% per year).

Earnings vs Industry: 46K earnings growth over the past year (14.1%) exceeded the Medical Equipment industry 10.1%.


Return on Equity

High ROE: 46K's Return on Equity (22.3%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 17:09
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IRADIMED CORPORATION is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Lawrence SolowCJS Securities, Inc.
Frank TakkinenLake Street Capital Markets, LLC
Scott HenryRoth MKM